Facebook
Twitter
LinkedIn
Forward
Join us for an in-depth webinar designed for clinicians and scientists, exploring the intricate relationship between the gut microbiome and obesity.
|
In th
|
Join us for an informative session designed to enhance your expertise in prescribing GLP1 medications for the treatment of obesity.
|
The 2024 Obesity Medicine Association (OMA) Annual Business Meeting hosted by Lydia Alexander, MD, MFOMA, President of the OMA.
|
This session will provide a practical guide to understanding and interpreting continuous glucose monitoring (CGM) data for healthcare providers managing patients with diabetes and obesity.
|
This session utilizes a direct instructional format to expand on the recent American Academy of Pediatrics Clinical Practice Guidelines for the Evaluation and Treatment of Children and Adolescents
|
The OMA Self-Assessment Program (SAP) is an essential tool for clinicians preparing for the American Board of Obesity Medicine (ABOM) Exam.
|
Obesity is a metabolic disease that requires lifelong lifestyle changes and in many patients who are overweight or obese, prescription medication.
|
Telemedicine offers a unique opportunity to expand access to obesity care.
|
This talk will explore the intricate relationship between the gut microbiome and obesity, shedding light on the critical role that microbes play in modulating body weight and metabolism.
|